Nucleoside reverse transcriptase inhibitors (NRTIs)

MCR 314 Pill - gray four-sided, 17mm

Pill with imprint MCR 314 is Gray, Four-sided and has been identified as Lamivudine 300 mg. It is supplied by Appco Pharma LLC.

Lamivudine is used in the treatment of Hepatitis B; HIV Infection; Occupational Exposure; Nonoccupational Exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Lamivudine (Lamivudine [ la-miv-ue-deen ])-MCR 314-300 mg-Gray-Four-sided

Lamivudine
Generic Name: lamivudine [ la-miv-ue-deen ]
Imprint: MCR 314
Strength: 300 mg
Color: Gray
Size: 17.00 mm
Shape: Four-sided
Availability: Prescription only
Drug Class: Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 55801-0314
Inactive Ingredients: Ferric oxide red, Hypromelloses, Magnesium stearate, Microcrystalline cellulose, Polyethylene glycol, Polysorbate 80, Sodium starch glycolate type A potato, Titanium dioxide,
Latest News
Related Drugs